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Abstract Phase contrast and epifluorescence microscopy
were utilized to monitor morphological changes in human
astrocytoma cells during a time-course exposure to singlewalled carbon nanotube (SWCNT) conjugates with different surfactants and to investigate sub-cellular distribution of the nanotube conjugates, respectively. Experimental
results demonstrate that cytotoxicity of the nanotube/surfactant conjugates is related to the toxicity of surfactant
molecules attached on the nanotube surfaces. Both sodium
dodecyl sulfate (SDS) and sodium dodecylbenzene sulfonate (SDBS) are toxic to cells. Exposure to CNT/SDS
conjugates (0.5 mg/mL) for less than 5 min caused changes in cell morphology resulting in a distinctly spherical
shape compared to untreated cells. In contrast, sodium
cholate (SC) and CNT/SC did not affect cell morphology,
proliferation, or growth. These data indicate that SC is an
environmentally friendly surfactant for the purification and
dispersion of SWCNTs. Epifluorescence microscopy analysis of CNT/DNA conjugates revealed distribution in the
cytoplasm of cells and did not show adverse effects on cell
morphology, proliferation, or viability during a 72-h
incubation. These observations suggest that the SWCNTs
could be used as non-viral vectors for diagnostic and
therapeutic molecules across the blood–brain barrier to the
brain and the central nervous system.
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Introduction
In recent years, increasing attention is being directed to the
structure, maintenance, and pathological disturbance of the
blood–brain barrier (BBB), particularly with regard to
enlarging a conceptual understanding of the signaling
pathways that exist between and among the constituent
cells of the BBB (i.e., endothelial cells, astrocytes, perivascular cells, and pericytes) [1]. A tight BBB can effectively protect the brain from many common bacterial and
selected, non-tissue specific viral infections, but can hinder
also the delivery of many effective diagnostic and therapeutic agents to the brain. Defeating this latter capability of
the BBB has been a particular interest of the pharmaceutical industry, especially with regard to delivery of successful chemotherapy against central nervous system
(CNS) tumors and other CNS neuropathologies [2].
Recently, an increasing number of observations have
demonstrated that nanoscale materials can be used as nonviral vectors to deliver therapeutic drugs and other small
molecules across the plasma membrane [3] or putatively
across the BBB [4–7]. The important implication of these
studies is this: when researchers or workers in the manufacturing sector handle nanoscale materials, these nanomaterials may not only remain on the skin and be inhaled
into the lungs, they could also be transported to the CNS.
Therefore, a critical evaluation of the potential cytotoxicity
of nanoscale materials on the brain must be executed
before we can safely use nanomaterials as drug vectors or
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in the manufacture of nanoscale electronics and optoelectronic devices.
Carbon nanotubes, especially single-walled carbon
nanotubes (SWCNTs), are among the most promising
nanoscale materials that have a broad range of applications,
including building blocks for future nanoscale devices and
vectors for drug delivery. Since their structures were
revealed by transmission electron microscopy by Iijima et al.
in 1993 [8], SWCNTs have been extensively investigated as
building blocks for nanoscale electronics, such as field effect
transistors (FET) [9, 10], interconnects [11], and electron
emitters [12]. In addition, a number of in vivo and in vitro
experiments showed that SWCNTs can effectively deliver
drugs, antibodies, and other biologically active molecules
into cells and tissues [13, 14]. In order to be useful for these
promising applications, SWCNTs need to be purified and
dispersed into individual nanotubes since synthesized
nanotubes occur in the form of bundles with accompanying
impurities such as metal catalyst particles and amorphous
carbon debris. One method to do this is by surfactant stabilization of the hydrophobic nanotube surfaces, which
overcomes the van der Waals forces among the nanotubes
and results in suspensions of individual SWCNTs. Several
surfactants, such as sodium dodecyl sulfate (SDS) [15, 16],
sodium dodecylbenzene sulfonate (SDBS) [16–19], and
sodium cholate (SC) [20], have been demonstrated to efficiently disperse bundled nanotubes into aqueous suspensions
of individual nanotubes. It is critical to understand the toxicity of the nanotube/surfactant conjugates since these
reagents are increasingly being used in manufacturing
industries and research laboratories. To our knowledge, there
has been no systematic study concerning cytotoxicity of
SWCNTs, especially carbon nanotube conjugates with the
extensively used SDS, SDBS, and SC surfactants, on the
brain and the CNS. In the brain, astrocytes serve important
roles in the BBB [1] and their functional repertoire keeps
expanding. For example, astrocytes are involved in regulating endothelial tight junctions [21], mediating cortical
vasodilation during neural activity [22], and propagating
intercellular Ca2? signaling waves between astrocyte networks and distant neurons [23]. For this study exploring the
cytotoxic effects of different surfactants conjugated to
SWCNTs on the brain, we selected 1321N1 human astrocytoma cells because they model an important cell constituent of the BBB, and they avoid the difficulties with
establishing and maintaining primary astrocyte cultures.
Recently, we utilized the CellTiter 96 Aqueous One
Solution (Promega) assay to study quantitatively the
cytotoxicity of SWCNT conjugates with SC, SDS, SDBS,
and single-stranded DNA (ssDNA) molecules on 1321N1
human astrocytoma cells [24]. Briefly, the toxicity of carbon nanotube conjugates was mainly controlled by the
surfactant molecules attached to the nanotube surfaces. The
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conjugates of SWCNTs with SDS and SDBS were toxic to
human astrocytoma cells, yet the nanotubes alone and the
nanotube conjugates with SC and ssDNA did not generate
obvious toxic responses. Since a cell viability or cytotoxicity assay requires at least 10 min to several hours of
incubation to generate a measurable signal (1–2 h for the
CellTiter 96 Aqueous One Solution), there could be some
interactions of the nanotubes as well as their conjugates
with the assay components. Consequently, we report here
an attempt to assess the cytotoxicity of SWCNT conjugates
for human astrocytoma cells by extending our previous
observations to the sub-10 min reaction time, by direct
observation with phase contrast light microscopy, and to
confirm penetration and localization of an SWCNT conjugate (ssDNA labeled with Cy5 fluorochrome) in astrocytoma cell cytoplasm.

Materials and Methods
Preparation of SWCNT Conjugates
To prepare an aqueous SWCNT solution, 1 mg of nanotube
powder (BuckyUSA Company) was dispersed in 1 mL of 1
wt% surfactant (SDS, SDBS, or SC) or Cy5-labeled singlestranded DNA [(GT)15, 1 mg/mL] solution. The suspension
was sonicated (Branson Ultrasonic, 130 W) for 60 min and
centrifuged (Eppendorf 5415R) at 16,000g for 60 min. After
centrifugation, the supernatant, containing individual
SWCNTs, was decanted. The precipitates, which contained
catalyst particles, bundled nanotubes, and amorphous carbon
debris, were discarded, and the nanotube concentration was
determined by UV–Vis spectrophotometer.
Cell Culture and Microscopy
Human 1321N1 astrocytoma cells were maintained and
assayed in Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) and
1% penicillin–streptomycin, and incubated at 37 °C in a
humidified 5% CO2 incubator.
To assess cell morphology over an exposure timecourse, 1,000 cells/well (estimated by a hemocytometer)
were seeded in 100 lL/well of culture medium in 96-well
culture plates and incubated at 37 °C in a humidified 5%
CO2 incubator for 24 h to allow the cells to settle and
adhere to the wells. After the cells were established, 5.0 lL
of 1% surfactant alone or nanotube/surfactant solution was
added to selected wells in triplicate. Observation of morphological changes was conducted under ambient atmosphere at room temperature (22–24 °C) using an Olympus
IX70 inverted microscope equipped with phase contrast
optics.

Nanoscale Res Lett (2009) 4:1517–1523

For epifluorescence microscopy experiments, 2,000 cells/
well in 500 lL/well of culture medium were seeded onto
11-mm glass coverslips in 24-well culture plates with
10.0 lL of CNT/DNA conjugate solution added to the
wells. After a 72-h incubation, the cells were washed three
times with standard phosphate-buffered saline, fixed with
4.0% paraformaldedyde for 5 min, counterstained with 40 ,
6-diamidino-2-phenylindole (DAPI), and mounted on glass
slides with Immunomount. Fixed cells were observed using
an Olympus BX60 epifluorescence microscope equipped
with a Retigia EX CCD camera. Images were acquired and
processed with ImagePro Plus (Media Cybernetics)
software.
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nanotube surface, but was not related to their anionic
characteristics. The SC molecules alone had no effect on
cell morphology or growth; apparently, the conjugates of
CNT/SC are not toxic to the cells. Human astrocytoma
cells did demonstrate a toxic response to conjugates of
CNT/SDBS and CNT/SDS because both SDBS and SDS
are toxic to the cells. Preliminary observations indicate that
SDS (Fig. 1g, h) may be more toxic to the astrocytoma
cells than SDBS (Fig. 1e, f) since the phase contrast
observations demonstrate cellular debris, possibly indicating cell lysis, at 30 min exposure.

Time-Course Morphological Changes Induced by
an Exposure to CNT/SDS Conjugates
Results and Discussion
Cytotoxicity of SWCNT Conjugates with Different
Surfactants
The morphology of human astrocytoma cells exposed to the
SWCNT/surfactant conjugates, CNT/SC, CNT/SDBS, or
CNT/SDS, was similar to the cellular morphology demonstrated by exposure to the corresponding surfactant solution
cargoes SC, SDBS, or SDS, respectively (Fig. 1). Without
the introduction of any surfactants or surfactant/nanotube
conjugates, control cells exhibit normal morphology and
growth even under ambient atmosphere at room temperature for several hours (Fig. 1a, taken at 1 h of incubation
under ambient atmosphere). Cells exposed to DNA, SC, and
CNT/SC (Fig. 1b–d) demonstrate normal cell morphology
when compared to the control conditions (Fig. 1a). Cells
undergoing mitosis are indicated by arrows. Phase contrast
images in Fig. 1 suggest that SC and the nanotube conjugates with DNA and SC had no effect on proliferation or
viability of human astrocytoma cells within 60 min.
In contrast, cells exposed to SDBS, CNT/SDBS, SDS,
and CNT/SDS demonstrate irregular cell morphology at
the 30 min time point, and no mitotic cells were observed.
Cells exposed to SDBS (Fig. 1e) and CNT/SDBS (Fig. 1f)
for 30 min show a distinct spherical morphology with
cytoplasmic processes apparently retracted compared to
untreated or SC-exposed cell morphology. Cells exposed to
SDS (Fig. 1g) and CNT/SDS (Fig. 1h) for 30 min exhibit a
similar spherical morphology with cellular debris visible in
the medium. The phase contrast images in Fig. 1 suggest
that SDBS and SDS and their nanotube conjugates
adversely affected cell morphology and growth within
30 min of exposure.
The anionic surfactants SC, SDBS, and SDS exhibited
different influences on cell morphology and viability. This
indicates that the toxicity of nanotube/surfactant conjugates
was controlled by the surfactant molecules attached on the

CNT/SDS conjugates affected cell viability within 30 min
of exposure (Fig. 1h). To further understand the earliest
appearance of morphological changes induced by nanotube/
conjugate exposure, a time-course study of changes was
recorded starting at time 0 min, at which time the CNT/SDS
conjugates were introduced into the growth medium
(Fig. 2a). Cells were observed at 2 min after introduction of
the CNT/SDS conjugates, at which time a few cells demonstrated retraction of their cytoplasmic processes
(Fig. 2b). After 5 min, a majority of cells assumed a nascent
spherical morphology with accompanying process retraction (Fig. 2c). At 10 min, virtually all cells demonstrated
reduced contact with the substratum and assumption of a
spherical morphology (Fig. 2d). Observations at 25 and
75 min revealed cellular debris in the culture medium
(Fig. 2e).
The time-course analysis shows that exposure to CNT/
SDS conjugates rapidly (within 2 min) and distinctly
affected cell morphology. Observations included potential
loss of membrane integrity, retraction of cytoplasmic processes, reduced cell-to-substratum adhesion, putative cell
shrinkage, and generation of cellular debris. Astrocytoma
cells exposed to CNT/SDS conjugates demonstrate characteristic morphological changes that are reminiscent of
apoptosis [25].
There are alternative interpretations regarding the toxicity of carbon nanotubes for both in vivo and in vitro
generated data. Some experimental results indicate that
introduction of carbon nanotubes into the growth medium
does not affect cell proliferation and viability [26–35], yet
other experiments demonstrate that structural variants of
carbon nanotubes do affect cell proliferation [36–39]. Our
time-course analysis (Figs. 1, 2) demonstrates that the
cytotoxicity of the tested nanotube conjugates was controlled by the surfactants attached to the nanotube surface,
and nanotubes alone do not affect cell proliferation and
growth.
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Fig. 1 Digital phase contrast
images of human astrocytoma
cells exposed to surfactants or
nanotube/surfactant conjugate
solutions under ambient
atmosphere at room
temperature: a control, 60 min;
b CNT/DNA, 60 min; c SC,
60 min; d CNT/SC, 60 min; e
SDBS, 30 min; f CNT/SDBS,
30 min; g SDS, 30 min; and h
CNT/SDS, 30 min. The
concentrations of surfactants
(b–h) and the SWCNTs (b, d, f,
and h) were 0.5 mg/mL and
2 lg/mL, respectively. Arrows
indicate proliferating cells. All
images were acquired at 2009
magnification directly from the
wells. Scale bar: 100 lm

Cellular Distribution of CNT/DNA Conjugates
The nanotube conjugates with SC and ssDNA did not
affect cell proliferation and growth. These observations
could be attributed to the conjugates remaining in the
extracellular environment and not being taken into astrocytoma cell cytoplasm. In order to explore whether the
nanotube conjugates can enter the cells or not, as well as
cellular distributions of the conjugates if they enter the
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cells, we utilized epifluorescence microscopy to initiate the
exploration, and the Cy5 fluorochrome attached to the
CNT/DNA conjugate was used to monitor the uptake of
these nanotube conjugates.
When the cells were exposed to the CNT/DNA conjugates for a time period less than 24 h, the fluorescence
signal was quite weak. In order to obtain a strong signal
and to investigate cytotoxicity of the nanotube conjugates
for a longer time period, adhering astrocytoma cells were

Nanoscale Res Lett (2009) 4:1517–1523
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Fig. 2 Phase contrast images of
a time-course of morphological
events observed in astrocytoma
cells after exposure to
0.5 mg/mL CNT/SDS conjugate
solutions for a 0 min; b 2 min;
c 5 min; d 10 min; e 25 min;
and f 75 min. All images were
acquired at 1009 magnification.
Scale bar: 200 lm

exposed to CNT/DNA-Cy5 conjugates for 72 h. After the
72-h incubation, the cells exhibit normal morphology and
proliferation (Fig. 3a). The CNT/DNA-Cy5 conjugates
were observed within the cytoplasm (Fig. 3b–d), indicating
that the conjugates were effectively transported into the
astrocytoma cells. Infrequently, fluorescence was detected
in a punctate pattern within the cell cytoplasm, with fluorescence signal detected over the nuclear region of some
cells (Fig. 3d). The question about the entry of the labeled
conjugate into, or exclusion from, the nuclear compartments could not be resolved from these images at this time.
No fluorescence was detected from untreated control cells
(data not shown). Some cytoplasmic regions demonstrate
more intense fluorescence; this focal intensity may represent clusters or bundles of the conjugates. The fluorescence
microscopy analysis demonstrates that CNT/DNA-Cy5
conjugates were distributed within the cytoplasm and did
not affect cell morphology. These results suggest that

SWCNTs could be used as vectors for diagnostic and
imaging contrast agent molecules into the brain and the
CNS across the blood–brain barrier since carbon nanotubes
can convey the ssDNA molecules into the cells, and their
conjugates did not affect the proliferation and growth of
astrocytoma cells. The next step is to investigate how to
target delivery of therapeutic and diagnostic agents and
how to release agent molecules inside the cells.

Conclusions
Time-course microscopy analysis demonstrates that the
cytotoxicity of nanotube/surfactant conjugates is related to
the toxicity of the surfactant molecules attached on the
nanotube surfaces. Human astrocytoma cells, exposed to
SDBS or SDS in the growth medium, experienced morphological changes including potential loss of plasma
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Fig. 3 Epifluorescence
microscopy of human
astrocytoma cells exposed to
CNT/DNA-Cy5 conjugates: a
phase contrast image; b merged
image of the phase contrast and
Cy5 images; c CNT/DNA-Cy5
(red) fluorescence image; and d
merged image of the CNT/
DNA-Cy5 and DAPI-stained
cells (blue). The concentration
of the CNT/DNA-Cy5 was
2 lg/mL. Images demonstrate
that nanotube/DNA conjugates
(red) can enter astrocytoma
cells and were localized in the
cytoplasm. Uptake of the
nanotube/DNA conjugate did
not affect cell proliferation and
viability. The nuclei were
stained with DAPI (blue). All
images were acquired at 1,0009
magnification. Scale bar: 50 lm

membrane integrity, altered attachment, putative cell
shrinkage, and generation of cellular debris. Cells exposed
to 0.5-mg/mL CNT/SDS conjugates exhibited nascent
morphological alterations within 2 min. Our data indicate
that SC could be used as an environmentally friendly
reagent for the dispersion and purification of SWCNTs.
Epifluorescence microscopy analysis of CNT/DNA conjugates indicates that these conjugates were efficiently
delivered into cells and distributed within the cytoplasm,
although the question of CNT conjugate penetration into
nuclei remains unresolved at this time. The precise mechanism for uptake of SWCNTs and SWCNT conjugates into
the cytoplasm of any cell type also remains unelucidated.
Since toxicity questions exist for the surfactants used to
disperse other nanoscale materials [40], the experimental
approach outlined in our study can be used to evaluate the
cytotoxicity of other nanoscale particles as well. SWCNTs
could be developed as non-viral vectors for diagnostic and
therapeutic molecules into the brain and the CNS across the
blood–brain barrier since their conjugates with ssDNA do
not affect the proliferation and growth of astrocytoma cells.
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